Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?
In: Joint bone spine, Jg. 91 (2024-05-01), Heft 3, S. 105662
editorialOpinion
Zugriff:
Titel: |
Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?
|
---|---|
Autor/in / Beteiligte Person: | Goupille, P ; Wendling, D |
Zeitschrift: | Joint bone spine, Jg. 91 (2024-05-01), Heft 3, S. 105662 |
Veröffentlichung: | Paris : Editions Elsevier, c2000-, 2024 |
Medientyp: | editorialOpinion |
ISSN: | 1778-7254 (electronic) |
DOI: | 10.1016/j.jbspin.2023.105662 |
Schlagwort: |
|
Sonstiges: |
|